PepHaūs Tirzepatide Review: Full Bills & Refund Stages

PepHaūs advertises compounded tirzepatide at $215 per month on a six-month plan billed $1,291, $227 per month on a quarterly plan billed $681, or $239 month to month. The six-month headline is rounded: budget the published $1,291 bill rather than substituting a calculated $1,290 total. Confirm the selected charge and recurring interval before authorizing a plan.^3,4

Choose the billed term, not only the monthly equivalent

The named product and cost pages say prices include the online provider visit, medication if prescribed, supplies and cold-chain shipping. The quarterly selection displays a $681 bill and a $227 monthly equivalent; confirm the shipment schedule rather than assuming it is collected in monthly installments.^3,4

The Telezen MD review provides a different quarterly comparison: tirzepatide is listed at $597 billed every three months, described as $199 per month, or $268 billed monthly. Compare the complete quarterly payment with the separate monthly option; the lower equivalent does not turn a three-month bill into cancelable monthly medication orders.¹⁰

A multi-month purchase does not establish that all medication arrives at once. Ask how many shipments occur during the paid term, the supplied quantity and pharmacy-label dates. A supplement comparison or branded-drug trial does not establish the outcomes of the actual compounded prescription.^3,4

Intake, prescription approval and recurring payment

The product FAQ says $0 is due at intake and the card is charged only if a provider prescribes. The Terms say payment is due when ordering and authorize recurring charges where applicable. Ask how intake authorization, prescription approval and the selected order relate, including what appears on the card before approval.^3,5

The Terms describe automatic renewal until canceled before the next billing date, at the then-current subscription price. Product copy says the starting price stays locked while enrolled. Obtain the applicable price and renewal authorization in the selected agreement, including any notice of a change, rather than treating a general price-lock statement as a substitute for the actual terms.^3,5

Pre-shipping cancellation is different from ending renewal

The April 22, 2026 refund policy permits a full refund before medication ships from the pharmacy. It also promises refunds of consultation fees and a prepaid first month if the provider declines treatment, with automatic subscription cancellation in that case.⁶

Ordinary subscription cancellation takes effect at cycle end and stops future charges. The current cycle is generally not refunded, except for an unshipped medication or another policy exception. Ask how that applies to a partly fulfilled multi-month plan.⁶

Damage or defects must be reported within seven days of delivery, with order details and photos. Missing shipments have a 30-day-from-shipment reporting window, and a carrier investigation may precede replacement or refund. Approved refunds are issued in 5–10 business days; this is not a guarantee that every request is approved or that bank posting occurs immediately.⁶

Confirm the prescriber and dispensing pharmacy

The Terms identify Pephaus LLC as the platform business and separate medical decisions from the platform. The product page identifies physicians affiliated with Wasef Health Group. Its how-it-works page attributes tirzepatide fulfillment to VialsRX, describes Hallandale for other therapies and refers to a network managed through Bask Health. Confirm which entities apply to the selected care arrangement; public role descriptions do not verify a patient’s assigned clinician or preparing/dispensing facility.^3,5,7

The site explains that location requirements can include a live visit. Confirm current availability, actual professionals and credentials, prescribed formulation and instructions before care. A public certificate or testing claim does not independently establish a particular vial’s contents, safety or equivalence.^7,8

Clinical evidence is separate from the service

Compounded tirzepatide is not an FDA-approved finished drug.⁹ SURMOUNT-1 and SURMOUNT-5 studied specific tirzepatide products and treatment protocols. They do not establish this provider’s outcomes or the equivalence of its compounded preparation, oral products or care model.^1,2 The actual prescription, risks, alternatives and administration instructions require an individual clinical assessment.

Further reading

whether compounded tirzepatide is still legal in 2026 · Zepbound side effects · the gallbladder risk · thyroid cancer warning · tirzepatide evidence guide · Ondra Health · NewSelf · best tirzepatide providers